×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Cervical Cancer

Kristie L. Kahl
The application is seeking approval for GARDASIL 9 to be used in women and men aged 27 to 45 years for the prevention of certain cancers and diseases caused by the nine human papillomavirus (HPV) types covered by the vaccine.
Brielle Urciuoli
The Food and Drug Administration approved Keytruda (pembrolizumab) for the treatment of certain patients with cervical cancer.
Jason Harris
Keytruda (pembrolizumab) was granted a priority review by the Food and Drug Administration (FDA) for the treatment of patients with advanced cervical cancer with disease progression or after chemotherapy.
 
Brielle Urciuoli
Treatment of HIV has drastically improved since the 1980s, but many of these individuals are still facing barriers to proper cancer care.
Brielle Urciuoli
This HPV-based test can help identify women who are at an increased risk for cervical cancer. 
Katie Kosko
A change Felder hopes to evoke is to get more cervical cancer survivors talking about the disease to help eliminate the stigma attached to having a below the belt cancer.
Stacy Chilton, LMSW
January is Cervical Health Awareness Month. Learn how women with cervical cancer can manage potential fertility concerns.
Katie Kosko
Radiation therapy alone reduced the number of cancer cells by 20 percent and the blueberry extract alone by 25 percent. But when combined, the blueberry extract and radiation therapy led to a 70 percent reduction in the number of human cervical cancer cells.
Brielle Urciuoli
“As the population of cancer survivors continues to grow, so does the importance of addressing the long-term sequelae of cancer treatment,” the authors wrote. “This hearing loss can result in multifaceted decrease in quality of life, and in pediatric patients it can impact social and academic development.”
Jason Harris
The Food and Drug Administration approved the first ever biosimilar to treat a variety of cancers.
 
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment

Caregiver

Healthcare Professional

Not Applicable